New insights from the TARGIT A trial 2021

Single-dose radiotherapy for breast cancer confirmed to be suitable for most patients:

New insights from the TARGIT-A trial Full paper can be accessed at https://doi.org/10.1038/s41416-021-01… and an invited blog post about it is here https://go.nature.com/3ymrplc

Previously published Improving breast cancer treatment: Long-term results of the TARGIT-A randomised trial (www.targit.org.uk) of risk-adapted single-dose TARGIT-IORT given during lumpectomy for breast cancer vs whole breast radiotherapy given post-operatively by visiting the radiotherapy centre daily for 3 to 6 weeks.

The full paper is available at https://www.bmj.com/content/370/bmj.m… The full paper PDF download: https://www.bmj.com/content/370/bmj.m… The accompanying opinion piece is at https://blogs.bmj.com/bmj/2020/08/19/…

UCL video is at https://youtu.be/5Xby04NBanY BMJ academic video is at https://youtu.be/aCnrDJ-NCWs Comparison of ‘no-radiotherapy’ trials, compressed whole breast radiotherapy trials and other partial breast irradiation randomised trial is published in Nature Reviews Clinical Oncology at https://static-content.springer.com/e… as part of the article https://www.nature.com/articles/s4157…

Comment published in British Journal of Cancer https://doi.org/10.1038/s41416-020-01… PDF download is at https://rdcu.be/cfcrV Slide credit – Jayant S Vaidya and Uma J Vaidya Worldwide adoption is described in this UCL Discovery preprint http://doi.org/10.14324/000.wp.10121050